Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Operating Expenses | 84,217 | 33,498 | 22,993 | 0 | 0 |
| Operating Income | -84,217 | -33,498 | -22,993 | N/A | N/A |
| Other Income | 1,540 | 910 | 29 | 0 | 0 |
| Pre-tax Income | -82,677 | -32,588 | -22,964 | 0 | 0 |
| Net Income Continuous | -82,677 | -32,588 | -22,964 | N/A | N/A |
| Net Income | $-82,677 | $-32,588 | $-22,964 | $N/A | $N/A |
| EPS Basic Total Ops | -8.13 | -31.14 | -35.68 | N/A | N/A |
| EPS Basic Continuous Ops | -7.48 | -25.93 | -32.30 | N/A | N/A |
| EPS Diluted Total Ops | -8.13 | -31.14 | -35.68 | N/A | N/A |
| EPS Diluted Continuous Ops | -7.48 | -25.93 | -32.30 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -8.13 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-82,164 | $-32,153 | $-22,278 | $N/A | $N/A |